human
coronavirus
hcov
respons
respiratori
tract
infect
rang
common
cold
sever
acut
respiratori
syndrom
two
four
hcov
circul
worldwid
close
phylogenet
rel
hcov
infect
lead
hospit
children
elderli
individu
immunocompromis
patient
global
approxim
upper
lower
respiratori
tract
infect
hospit
children
caus
latter
viru
recent
associ
childhood
diseas
croup
thu
differenti
two
virus
relev
epidemiolog
studi
aim
studi
develop
doubleantibodi
sandwich
enzymelink
immunosorb
assay
daselisa
potenti
tool
identif
differenti
nucleocapsid
n
protein
express
escherichia
coli
system
use
immun
mice
order
obtain
monoclon
antibodi
mab
specif
viru
three
specif
mab
one
mab
specif
four
mab
recogn
virus
obtain
character
three
mab
select
order
develop
differenti
daselisa
describ
assay
could
detect
ngml
n
protein
tissu
cultur
infect
dosesml
viru
stock
crossreact
human
coronavirus
close
relat
anim
coronavirus
found
coronavirus
cov
larg
envelop
positivestrand
rna
virus
belong
famili
coronavirida
basi
serolog
crossreact
sequenc
analysi
coronavirus
classifi
three
distinct
group
alphaand
betacoronaviru
group
harbor
variou
mammalian
cov
wherea
avian
virus
cluster
gammacoronaviru
group
five
differ
human
cov
hcov
speci
associ
respiratori
tract
infect
rang
common
cold
sever
acut
respiratori
syndrom
sar
belong
alphacoronaviru
group
two
human
cov
rel
close
phylogenet
relationship
discov
person
common
cold
isol
first
time
infant
bronchiol
infect
worldwid
distribut
peak
activ
winter
month
virus
associ
upper
lower
respiratori
tract
diseas
frequent
affect
young
children
case
infect
lead
sever
clinic
symptom
although
acut
infect
infant
elderli
individu
immunocompromis
patient
caus
seriou
respiratori
diseas
may
requir
hospit
global
approxim
upper
lower
respiratori
tract
infect
hospit
children
caus
infect
clinic
manifest
infect
person
headach
nasal
discharg
chill
cough
sore
throat
wherea
symptom
observ
patient
sever
includ
fever
cough
sore
throat
bronchiol
pneumonia
moreov
recent
associ
childhood
diseas
croup
reinfect
occur
throughout
life
current
therapeut
treatment
avail
hcov
diagnosi
base
viru
detect
revers
transcriptionpcr
technolog
sever
studi
describ
develop
immunoassay
use
nucleocapsid
n
protein
detect
antibodi
human
coronavirus
n
protein
abundantli
express
infect
highli
immunogen
featur
support
nucleocapsid
protein
potenti
sourc
antigen
detect
cov
infect
highli
relat
phylogenet
although
produc
differ
diseas
caus
sever
therefor
differenti
virus
import
issu
due
close
genet
relationship
serolog
differenti
complex
therefor
aim
studi
describ
present
report
establish
doubleantibodi
sandwich
enzymelink
immunosorb
assay
daselisa
capabl
detect
distinguish
mention
background
n
protein
appear
suitabl
candid
use
viral
detect
homolog
amino
acid
sequenc
n
protein
n
protein
report
vari
therefor
n
protein
express
escherichia
coli
system
use
immun
mice
order
obtain
monoclon
antibodi
mab
specif
viru
therefor
allow
differenti
virus
cell
cell
grown
maintain
co
atmospher
use
mixtur
hank
earl
minimum
essenti
tissu
cultur
medium
invitrogen
supplement
fetal
calf
serum
fc
antibiot
penicillin
streptomycin
cell
maintain
co
atmospher
dulbecco
modifi
eagl
minimum
essenti
medium
dmem
supplement
fc
antibiot
penicillin
streptomycin
vero
cell
maintain
co
atmospher
dmem
supplement
fc
isol
amsterdam
passag
obtain
viru
cultur
cell
describ
previous
isol
passag
obtain
viru
cultur
cell
day
co
infecti
titer
viru
stock
determin
accord
reed
muench
formula
cell
monolay
porcin
epidem
diarrhea
viru
pedv
propag
vero
cell
grow
dmem
without
fetal
bovin
serum
supplement
streptomycin
penicillin
g
gml
trypsin
tryptos
phosphat
broth
yeast
extract
h
co
viru
harvest
supernat
sever
cycl
freezethaw
cultur
supernat
clarifi
lowspe
centrifug
concentr
ultracentrifug
purifi
sucros
gradient
mockinfect
vero
cell
treat
way
use
control
antigen
antigen
prepar
recombin
n
protein
prepar
use
escherichia
coli
system
describ
previous
briefli
n
gene
viru
amplifi
clone
vector
invitrogen
recombin
n
protein
express
transform
strain
rosetta
novagen
cell
overnight
cultur
transform
bacteria
inocul
luria
broth
medium
supplement
glucos
carbenicillin
chloramphenicol
cultur
grown
exponenti
phase
prior
induct
iptg
h
recombin
protein
purifi
nickelnitrilotriacet
acid
agaros
qiagen
ctermin
halv
n
protein
amino
acid
aa
aa
express
purifi
follow
protocol
one
use
prepar
fulllength
protein
recombin
n
protein
prepar
follow
protocol
virusinfect
cell
lysat
prepar
stock
inactiv
triton
trinbutyl
phosphat
tnbp
h
room
temperatur
rt
purifi
pedv
use
antigen
elisa
immun
mice
four
femal
balbc
strain
mice
inject
subcutan
g
purifi
n
protein
first
immun
done
complet
freund
adjuv
cfa
difco
two
dose
done
incomplet
freund
adjuv
ifa
interv
mice
receiv
final
booster
inject
g
antigen
phosphatebuff
salin
pb
consecut
day
prior
hybridoma
fusion
product
monoclon
antibodi
product
hybridoma
secret
virusspecif
mab
carri
follow
modifi
version
procedur
previous
describ
briefli
myeloma
cell
fuse
splenocyt
immun
mice
use
polyethylen
glycol
peg
sigmaaldrich
fusion
hybrid
cell
elut
dmem
gibco
contain
fc
gibco
coat
well
plate
concentr
cellswel
h
hypoxanthineaminopterinthymidin
medium
hybridoma
clone
factor
roch
ad
renew
everi
h
period
day
day
cultur
medium
hybridoma
screen
reactiv
correspond
recombin
n
protein
elisa
antibodyproduc
hybridoma
clone
limit
dilut
least
four
time
antibodi
select
done
use
correspond
nucleocapsid
protein
unrel
viral
protein
prepar
way
n
protein
use
negativecontrol
antigen
elisa
final
select
hybridoma
use
inocul
balbc
mice
result
mab
purifi
ascit
fluid
precipit
capryl
acid
label
peroxidas
accord
method
describ
nakan
kawaoi
character
character
monoclon
antibodi
specif
mab
determin
indirect
elisa
western
blot
analysi
use
recombin
n
protein
correspond
virusinfect
cell
lysat
antigen
indirect
elisa
purifi
mab
incub
microtit
plate
coat
gwell
purifi
recombin
n
protein
gwell
ctermin
half
n
protein
virusinfect
cell
lysat
plate
block
stabilzym
select
surmod
inc
mn
h
rt
bound
antibodi
detect
dilut
horseradish
peroxidas
hrp
label
goat
antimous
immunoglobulin
sigmaaldrich
h
incub
rt
follow
extens
wash
plate
incub
tetramethylbenzidin
tmb
substrat
tmbmax
neogen
corpor
lexington
ky
reaction
stop
addit
sulfur
acid
absorb
measur
nm
multiscan
ascent
elisa
reader
western
blot
analysi
carri
electrophores
protein
prepar
sodium
dodecyl
sulfat
sd
polyacrylamid
gel
reduc
condit
detect
antigen
follow
immunoblot
use
select
hybridoma
supernat
goat
antimous
immunoglobulin
conjug
peroxidas
secondari
antibodi
specif
band
visual
use
tmb
substrat
isotyp
mab
determin
elisa
use
specif
antimous
subtyp
antisera
sigma
competit
elisa
differ
mab
perform
order
detect
map
differ
antigen
area
briefli
plate
coat
correspond
recombin
purifi
n
protein
gwell
dilut
sodium
carbon
buffer
ph
incub
overnight
plate
block
h
rt
predetermin
limit
dilut
peroxidaselabel
mab
ad
well
presenc
serial
dilut
unlabel
competitor
h
incub
follow
extens
wash
plate
incub
substrat
tmb
subsequ
develop
assay
perform
describ
indirect
elisa
neg
optic
densiti
nm
od
obtain
antibodi
compet
indic
map
antigen
area
contrast
two
antibodi
map
differ
region
result
od
posit
daselisa
microtit
plate
coat
gwell
purifi
mab
mgml
dilut
sodium
carbon
buffer
ph
plate
incub
plate
block
h
rt
recombin
n
protein
ctermin
half
n
protein
correspond
virusinfect
cell
lysat
dilut
tween
pb
ad
plate
plate
incub
h
rt
mab
specif
viru
conjug
peroxidas
mab
respect
subsequ
use
antigen
detect
incub
h
rt
tmb
peroxidas
substrat
ad
reaction
stop
addit
sulfur
acid
enzymat
activ
measur
determin
od
elisa
plate
reader
wash
consecut
step
perform
tween
pb
fect
cell
lysat
antigen
perform
test
specif
mab
result
show
mab
could
classifi
three
group
accord
specif
first
group
includ
mab
specif
mab
second
group
includ
mab
specif
mab
final
third
group
mab
recogn
virus
mab
isotyp
mab
analyz
antibodi
classifi
classifi
classifi
describ
characterist
mab
summar
tabl
abil
mab
bind
recombin
protein
investig
western
blot
analysi
mab
suitabl
use
immunoblot
result
consist
elisa
result
figur
show
exampl
reactiv
one
mab
repres
group
mab
show
reactiv
protein
correspond
expect
molecular
mass
recombin
n
protein
fig
mab
show
reactiv
protein
correspond
expect
molecular
mass
recombin
n
protein
final
mab
show
crossreact
n
protein
virus
fig
c
respect
competit
elisa
antibodi
belong
group
done
determin
whether
map
differ
antigen
region
protein
result
indic
mab
specif
n
protein
map
differ
antigen
area
protein
competit
antibodi
recogn
virus
done
result
show
compet
indic
map
region
protein
data
shown
first
attempt
local
region
nucleocapsid
protein
recogn
mab
fragment
cover
ctermin
half
n
protein
aa
aa
express
e
coli
system
prepar
way
use
fulllength
antigen
describ
materi
method
equimolar
amount
fulllength
protein
correspond
fragment
use
coat
plate
condit
antibodi
react
region
protein
reactiv
found
either
mab
fig
mab
bound
ctermin
end
protein
reactiv
fragment
even
higher
reactiv
observ
complet
molecul
fig
antibodi
recogn
virus
react
region
protein
reactiv
similar
thu
fig
show
reactiv
mab
repres
exampl
group
daselisa
daselisa
first
set
use
purifi
recombin
n
protein
antigen
possibl
combin
mab
test
five
mab
common
virus
mab
select
captur
antibodi
optim
specif
antibodi
label
peroxidas
speci
chosen
detect
detect
assay
could
detect
ngml
recombin
n
protein
ngml
recombin
n
protein
experi
done
virusinfect
cell
lysat
antigen
previous
inactiv
treatment
triton
tnbp
h
rt
specif
assay
demonstr
case
detect
limit
approxim
tissu
cultur
infect
dose
tcid
ml
viral
stock
virus
result
daselisa
use
viru
lysat
antigen
shown
fig
result
confirm
specif
assay
crossreact
n
protein
cov
reactiv
mab
n
protein
human
coronavirus
belong
betacoronaviru
group
examin
indirect
elisa
daselisa
result
assay
show
none
mab
crossreact
virus
data
shown
crossreact
cov
anim
origin
belong
alphacoronaviru
group
pedv
close
relat
also
test
result
neg
od
indirect
elisa
data
shown
describ
antibodi
even
recogn
virus
detect
viral
antigen
andor
viral
genom
critic
rapid
diagnosi
respiratori
viral
infect
follow
appropri
treatment
current
revers
transcriptionpcr
major
techniqu
use
diagnosi
hcov
infect
howev
method
disadvantag
possibl
contamin
instabl
rna
sampl
need
special
equip
case
particular
undevelop
countri
avail
rapid
test
need
order
facilit
diagnosi
antigencaptur
elisa
use
mab
allow
rapid
diagnosi
viral
infect
use
altern
pcr
basi
low
degre
homolog
among
amino
acid
sequenc
n
protein
differ
coronavirus
togeth
high
immunogen
protein
n
protein
appear
suitabl
antigen
marker
diagnosi
coronaviru
infect
work
report
describ
product
character
sever
speciesspecif
mab
n
protein
human
coronavirus
subsequ
develop
differenti
elisa
allow
detect
immun
balbc
mice
recombin
n
protein
led
product
sever
mab
antibodi
speci
specif
other
abl
recogn
virus
tabl
addit
result
immunoblot
experi
suggest
epitop
recogn
mab
linear
rather
conform
fig
first
attempt
narrow
locat
epitop
recogn
antibodi
fragment
cover
ctermin
half
n
protein
express
test
elisa
differ
mab
previous
describ
ntermin
half
cov
n
protein
contain
highli
conserv
motif
howev
two
differ
fusion
n
protein
n
protein
two
eight
mab
bind
ctermin
half
n
protein
fig
indic
amino
region
less
immunogen
least
mice
find
agre
previou
studi
sar
coronaviru
n
protein
describ
immunoreact
epitop
locat
ctermin
end
protein
local
develop
mab
part
protein
also
support
result
competit
elisa
thu
mab
specif
mab
react
differ
part
protein
indirect
elisa
compet
suggest
map
differ
area
protein
contrast
mab
recogn
virus
mab
react
similar
way
c
terminu
protein
indirect
elisa
compet
indic
map
region
close
region
detail
studi
ctermin
end
sequenc
n
protein
reveal
although
overal
homolog
differ
speci
low
fragment
includ
two
region
kprwkr
qcf
gpr
well
conserv
among
virus
one
conserv
ngvxakg
fig
observ
togeth
result
lead
conclus
conserv
sequenc
probabl
includ
epitop
select
common
mab
although
experi
use
peptid
done
order
answer
question
shown
fig
reactiv
mab
specif
ctermin
fragment
stronger
reactiv
fulllength
protein
could
due
structur
protein
epitop
becom
access
fragment
complet
protein
character
differ
mab
doubleantibodi
sandwich
elisa
develop
antigen
detect
mab
select
captur
antibodi
mab
conjug
peroxidas
use
detect
antibodi
respect
result
daselisa
demonstr
mab
speci
specif
recombin
n
protein
use
antigen
also
true
virusinfect
cell
lysat
use
fig
besid
use
one
mab
abl
captur
virus
make
develop
assay
simpler
less
expens
import
advantag
commerci
purpos
final
crossreact
virus
belong
betacoronaviru
group
found
crossreact
coronaviru
anim
origin
belong
alphacoronaviru
group
pdev
found
result
somehow
expect
sinc
mab
map
ctermin
half
protein
variabl
region
addit
result
strongli
confirm
assay
specif
although
futur
experi
use
human
respiratori
sampl
done
current
find
show
present
daselisa
potenti
tool
detect
differenti
infect
assay
could
use
valid
altern
nucleic
acid
detect
cov
diagnost
purpos
moreov
combin
use
daselisa
pcr
may
help
possibl
